Table 5 Sex differences of characteristics in JIA-U patients
Variables | N | Male | N | Female | P | OR (95%CI) |
|---|---|---|---|---|---|---|
mean age as of April 2016 | 13 | 11.5 ± 4.7 | 28 | 13.8 ± 6.4 | 0.3737 |  |
mean age at uveitis diagnosis | 13 | 6.5 ± 3.0 | 28 | 5.2 ± 2.8 | 0.2207 |  |
mean age at arthritis onset | 13 | 4.5 ± 3.0 | 28 | 2.3 ± 1.9 | 0.0324 |  |
mean serum MMP-3 (ng/ml) at JIA diagnosis | 11 | 145.9 ± 150.8 | 20 | 139.8 ± 109.8 | 0.69 |  |
ANA ≥1:160 | 13 | 5 (38.5%) | 31 | 17 (54.8%) | 0.5098 | 0.51(0.14~1.93) |
bilateral uveitis at uveitis diagnosis | 13 | 6 (46.2%) | 26 | 15 (57.7%) | 0.52 | 0.63(0.16~2.4) |
anterior uveitis at uveitis diagnosis | 12 | 7 (58.3%) | 17 | 16 (94.1%) | 0.0563 | 0.09(0.01~0.89) |
without eye symptoms at uveitis diagnosis | 12 | 4 (33.3%) | 27 | 20 (74.1%) | 0.0306 | 5.71(1.3~25.0) |
with complications at uveitis diagnosis | 12 | 6 (50.0%) | 26 | 8 (30.8%) | 0.296 | 2.25(0.55~9.17) |
with complications at the last visit | 13 | 9 (69.2%) | 28 | 13 (46.4%) | 0.2 | 2.6(0.65~10.5) |
with persistent uveitis activity at the last visit | 13 | 10 (76.9%) | 28 | 8 (28.6%) | 0.0063 | 8.33(1.8~38.4) |